“Don’t underestimate the importance of aligning the interests of different stakeholders,” says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
How to Make Oil (IT) and Water (Physicians) Mix in Precision Medicine Initiatives Read More »
The need to build up critical mass quickly may tempt hospital and health system leaders to cut corners when it comes to being forthcoming with patients. Don’t fall into that trap…
Considering a Precision Medicine Data Storage Partnership? Beware of Privacy Pitfalls Read More »
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access…
The Good News and Bad News About Where Precision Medicine Stands in 2020 Read More »
With precision medicine gaining momentum as a guiding approach to healthcare practice and treatments, early pharmacogenomic testing in the consumer market is laying some of the foundation for use in psychiatry…
Clinicians Looking for Guidance on Pharmacogenomic Testing in Psychiatry Read More »
Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes…
To Demonstrate Precision Medicine Utility, Focus on Pharmacogenetics Studies and Data Read More »
Focusing on the right factors can accelerate a precision medicine program’s ROI…
Precision Medicine Programs Can Attain ROI Sooner Than Some Naysayers Maintain Read More »
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions…
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes…
UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer Read More »
Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits…
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer….
Do Multigene Panels Offer Cancer Patients, Payers More Value? Read More »
